ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Chandigarh: A continuing medical education on sleep-related breathing disorders and a hands-on workshop on allergy was ...

Former Sri Lanka cricket legend Arjuna Ranatunga has stunned fans with his remarkable weight loss transformation. The World ...

VA vowed to modernize its disability benefits system. As criticism from veterans and their advocates has mounted, efforts to ...

Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in diverse patient populations and post-bariatric surgery ...

The Food and Drug Administration has approved a GLP-1 agonist for treating sleep apnea. Here’s how it works and what you can ...

A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide recommendations for the management of obstructive sleep apnea in medically hospitalized adults.

Obstructive Sleep Apnea (OSA) is a common yet underdiagnosed sleep disorder characterized by repetitive upper airway collapse during sleep, leading to ...

Addressing airflow complications in the nasal airway in patients with allergies can greatly improve sleep disordered breathing. Allergens irritate the tissue in the nasal passages and can make you ...

For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen and a jaw-forwarding device, can dramatically cut breathing interruptions ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 2 minutes ...